Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
Call for new iCAN subproject proposals 2025-2026 open now
The iCAN Flagship Project had a large call in 2022 for new subproject applications for the second term (2023 – 2026)….
New iCANDOC Precision Cancer Medicine doctoral researchers starting
A total of 93 doctoral researchers were recently selected in calls at the University of Helsinki, Tampere University, and University…
iCAN kansallinen ohjelma käynnistyi: 2,5 miljoonan euron rahoitus alueellisille syöpäkeskuksille biopankkihankkeisiin
Kansallisen syöpäkeskus FICANin puitteissa käynnistyvät hankkeet tulevat vahvistamaan syövän molekyyliprofilointia koko Suomessa. Hankkeet ovat osa iCAN-tutkimushanketta. Tavoitteena on kehittää valmiuksia syövän…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding